CureTalks Webinar: Climbing Mount Kilimanjaro for the MMRF with Myeloma Patient Advocate Matt Goldman

April 16th, 2018 •
September 26, 2017
UPCOMING /Recent Talks

CureTalks Webinar: Climbing Mount Kilimanjaro for the MMRF with Myeloma Patient Advocate Matt Goldman 

 with Matt Goldman
September 26th, 2017. 6PM EST RSVP
In February 2017, along with 5 other patients and 10 individuals who have had their lives impacted with myeloma, Matt Goldman climbed Mount Kilimanjaro in Tanzania, Africa. They were raising funds for Multiple Myeloma Research foundation (MMRF), which is a leading organization working to find  myeloma cure. Kilimanjaro is 19,000 feet high. The journey took 8 days where they covered over 40 miles. Matt says " I feel quite fortunate. Reaching the peak was a life changing and life defining moment." Join us to hear Matt relive his experience.
 Panelists
Matt Goldman
Shweta Mishra 
Priya Menon
CureTalks Webinar: Stress and Infertility - Understanding the Connection
with Dr. Parijat Deshpande 
September 14th, 2017. 1:30 PM EST LISTEN
Relationship of our mental state and fertility is a very complex one. Can stress cause infertility? Does stress impact ovulation? Can treating stress improve pregnancy rates? How does stress affect fertility in men and women? For answers, we are turning to Dr. Parijat Deshpande who specializes in lifestyle medicine and guide women to lower stress and improve their overall wellness to have a safer pregnancy.
 Panelists
Dr. Parijat Deshpande 
Shweta Mishra
Multiple Myeloma: Minimal Residual Disease Testing as an End Point Treatment
  with Dr. Ola Landgren 
August 31st, 2017. 6PM EST LISTEN
Most myeloma patients, even those in complete response may show signs of relapse at some point of time. So testing and quantifying Minimal Residual Disease (MRD) has become essential to obtain better prognostics correlations. Researchers believe that MRD testing could help them compare myeloma therapy strategies, evaluate new treatment faster, and guide treatment decisions. The myeloma panelists are talking to Dr. Ola Landgren, a lead researcher in the field, on what MRD testing could mean to your treatment, and about how MRD testing could become a new and earlier end-point in myeloma treatment.   Panelists
Dr. Ola Landgren
Gary Petersen 
Jack Aiello
Cynthia Chmielewski
Matt Goldman
For any of the talks dial-in to 718-664-6574 to participate and ask a question LIVE On-Air! Only 50 callers permitted at one time so HURRY!
Our Picks
Story Penn study shows 80 percent of activity tracker users stick with the devices for at least six months 
WIDGET Dory - Find your clinical trials here!
Categories:
Tags: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , ,
0
20965

Related Posts